Regulatory Head of Regenerative Medicine & Advanced Therapy
Why I'm a JPAL
Support of novel ideas is fundamental to bringing much needed solutions to health issues globally. I am a JPAL to foster collaboration and help bring novel ideas forward.
Katherine has almost 30 years of progressive global regulatory experience in small and large sized Pharma companies. She has worked on products at various stages of development, from early through to filing, approval and commercialization. Currently, Katherine is the Janssen Regulatory Head of Regenerative Medicine & Advanced Therapy (RMAT), and the Johnson & Johnson Director of the RMAT Network. In these roles, she ensures global regulatory policy strategies contribute to and support development plans for RMAT products across several therapeutic areas, and facilitates J&J enterprise wide efforts to enhance awareness and connectivity for the development of process that enable assessing, partnering, and developing safe and effective advanced therapies globally. In addition, she represents Global Regulatory Affairs (GRA) on the J&J First in Human Committee, and she leads the Real World Evidence (RWE) Regulatory team and represents GRA on the cross-functional RWE Leadership team. Katherine received her Bachelor of Science Biology from Temple University, Juris Doctorate from Widener University Law School, and is admitted to the practice of law in Pennsylvania and New Jersey.
Unless someone like you cares a whole awful lot. Nothing is going to get better. It's not.
My family owns a motocross track.